Skip to main content
Novo Nordisk A/S (NONOF)
OTCMKTS · Delayed Price · Currency is USD
68.25
+1.77 (2.66%)
Jun 27, 2025, 3:59 PM EDT

Novo Nordisk Revenue

Novo Nordisk had revenue of 78.09B DKK in the quarter ending March 31, 2025, with 19.49% growth. This brings the company's revenue in the last twelve months to 303.14B, up 24.11% year-over-year. In the year 2024, Novo Nordisk had annual revenue of 290.40B with 25.03% growth.

Revenue (ttm)
303.14B DKK
Revenue Growth
+24.11%
P/S Ratio
6.94
Revenue / Employee
3.92M DKK
Employees
77,349
Market Cap
304.96B USD

Revenue Chart

* This company reports financials in DKK.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024290.40B58.14B25.03%
Dec 31, 2023232.26B55.31B31.26%
Dec 31, 2022176.95B36.15B25.68%
Dec 31, 2021140.80B13.85B10.91%
Dec 31, 2020126.95B4.93B4.04%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo, Inc. 1.73B
Elite Pharmaceuticals 70.00M
Veradigm 588.02M
Tian'an Technology Group 1.78M
American Oncology Network 1.76B
Glass House Brands 215.62M
Northwest Biotherapeutics 1.47M
Silence Therapeutics 27.70M
Revenue Rankings

Novo Nordisk News

More News